Eiko LifeSciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	117.81	133.46	6.12	2.17	40.72
Short-Term Investments	-	-	-	-	-	24.72
Cash & Short-Term Investments	80.87	117.81	133.46	6.12	2.17	65.44
Cash Growth	158.22%	-11.73%	2079.30%	181.82%	-96.68%	1241.42%
Accounts Receivable	-	107.86	131.34	71.06	45.62	34.15
Other Receivables	-	-	-	-	-	3.96
Receivables	-	107.86	131.34	71.06	45.62	38.11
Inventory	-	57.75	33.86	9.08	54.58	0.64
Prepaid Expenses	-	-	0.06	0.6	0.19	-
Other Current Assets	-	45.36	10.57	6.16	31.95	2.83
Total Current Assets	-	328.77	309.29	93.01	134.51	107.02
Property, Plant & Equipment	-	231.19	135.65	138.81	142.89	2.48
Long-Term Investments	-	71.54	40.18	11.76	58.67	20.29
Long-Term Deferred Tax Assets	-	-	-	-	-	0.24
Other Long-Term Assets	-	29.51	41.42	43.7	-	-
Total Assets	-	661.01	527.39	310.43	348.94	166.14
Accounts Payable	-	33.15	13.81	10.45	13.49	18.95
Accrued Expenses	-	3.13	0.33	0.86	0.65	3.17
Short-Term Debt	-	7.55	-	-	45	16.31
Current Portion of Long-Term Debt	-	-	-	0.54	0.75	0.68
Current Income Taxes Payable	-	2.36	0.64	-	-	0.49
Other Current Liabilities	-	16.47	0.27	0.14	0.18	-
Total Current Liabilities	-	62.65	15.05	11.99	60.06	39.6
Long-Term Debt	-	20.08	-	-	0.54	1.28
Long-Term Deferred Tax Liabilities	-	8.21	5.56	4.22	2.05	-
Other Long-Term Liabilities	-	0	-	-	-0	-
Total Liabilities	-	90.95	20.61	16.21	62.64	40.88
Common Stock	-	137.63	128.73	83.16	83.16	38.2
Additional Paid-In Capital	-	375.2	344.06	184.58	184.58	12
Retained Earnings	-	55.06	34	26.48	18.56	11.66
Comprehensive Income & Other	-	-0	-	-	-	63.4
Total Common Equity	587.78	567.89	506.78	294.22	286.3	125.26
Minority Interest	-	2.18	-	-	-	-
Shareholders' Equity	594.08	570.06	506.78	294.22	286.3	125.26
Total Liabilities & Equity	-	661.01	527.39	310.43	348.94	166.14
Total Debt	10.09	27.63	-	0.54	46.28	18.27
Net Cash (Debt)	70.78	90.17	133.46	5.59	-44.1	47.18
Net Cash Growth	161.60%	-32.44%	2288.33%	-	-	-
Net Cash Per Share	5.19	6.92	12.94	0.57	-5.65	12.35
Filing Date Shares Outstanding	13.71	13.86	13.86	8.32	8.32	3.83
Total Common Shares Outstanding	13.71	13.86	13.86	8.32	8.32	3.83
Working Capital	-	266.11	294.24	81.03	74.45	67.42
Book Value Per Share	42.62	40.97	36.56	35.38	34.43	32.73
Tangible Book Value	587.78	567.89	506.78	294.22	286.3	125.26
Tangible Book Value Per Share	42.62	40.97	36.56	35.38	34.43	32.73
Buildings	-	53.41	38.57	38.29	38.11	-
Machinery	-	87.85	89.7	87.28	85.2	5.15
Leasehold Improvements	-	28.63	28.63	27.88	27.88	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.